MediPharm Labs Corp.
LABS.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.83% | 0.46% | -18.53% | -35.14% | -52.71% |
| Total Receivables | -13.45% | 5.18% | 11.91% | 29.31% | 13.67% |
| Inventory | -17.01% | -3.80% | -14.97% | -3.41% | 1.38% |
| Prepaid Expenses | -18.64% | -16.59% | -22.40% | -14.53% | -29.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -92.82% | -91.46% | -90.57% | -79.60% | 270.04% |
| Total Current Assets | -16.49% | -12.87% | -21.63% | -21.89% | -13.85% |
|
|
|||||
| Total Current Assets | -16.49% | -12.87% | -21.63% | -21.89% | -13.85% |
| Net Property, Plant & Equipment | -5.34% | -3.62% | -11.33% | -7.56% | -27.62% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.47% | -17.05% | -22.24% | -18.69% | -22.79% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -40.23% | -39.26% |
| Total Assets | -13.52% | -10.67% | -19.07% | -17.31% | -19.91% |
|
|
|||||
| Total Accounts Payable | -3.63% | 16.78% | 30.94% | 74.72% | 27.30% |
| Total Accrued Expenses | 36.63% | -12.79% | -56.70% | -47.75% | -47.54% |
| Short-term Debt | -- | -38.98% | -40.38% | -83.35% | -99.34% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -76.84% | -32.24% | 45.63% | 58.16% | -5.75% |
| Total Finance Division Other Current Liabilities | -33.30% | -6.27% | -16.86% | 13.61% | -11.63% |
| Total Other Current Liabilities | -33.30% | -6.27% | -16.86% | 13.61% | -11.63% |
| Total Current Liabilities | -0.09% | -0.75% | -21.25% | -21.91% | -26.81% |
|
|
|||||
| Total Current Liabilities | -0.09% | -0.75% | -21.25% | -21.91% | -26.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -38.98% | -40.38% | -83.35% | -99.34% |
| Capital Leases | -- | -- | -- | -78.72% | -49.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.44% | -1.23% | -21.51% | -22.13% | -26.92% |
|
|
|||||
| Common Stock & APIC | 3.58% | 5.30% | -2.68% | 0.70% | -5.42% |
| Retained Earnings | 6.42% | 5.17% | 1.48% | -2.31% | 1.89% |
| Treasury Stock & Other | -88.10% | -88.27% | -19.10% | -16.34% | -5.63% |
| Total Common Equity | -16.19% | -12.98% | -18.49% | -16.07% | -18.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.19% | -12.98% | -18.49% | -16.07% | -18.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -16.19% | -12.98% | -18.49% | -16.07% | -18.31% |
|
|
|||||